RICHARD HAIDUCK, DIRECTOR, BURRILL AND COMPANY/BIOSTREET TO PRESENT AT IBC LIFE SCIENCES INAUGURAL ANTIBODY PARTNERING & COLLABORATION EVENT

IBC has announced that Richard Haiduck of Burrill and Company/Biostreet will present the Keynote Address at this inaugural meeting to be held on March 3-4, 2003 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Co-Located with Process Validation for Biologicals held March 3-4, 2003 and Antibody Production & Downstream Processing held March 5-7, 2003, this event is considered ¡§THE¡¨ Networking Forum for Finding and Keeping Profitable Partners. The networking opportunities will be unparalleled due to the co-location of these premier events and Antibody Production & Downstream Processing celebrating 10 years serving the industry.

Westborough, MA, January 10, 2002 ¡V IBC has announced that Richard Haiduck of Burrill and Company/Biostreet will present the Keynote Address at this inaugural meeting to be held on March 3-4, 2003 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Co-Located with Process Validation for Biologicals held March 3-4, 2003 and Antibody Production & Downstream Processing held March 5-7, 2003, this event is considered ¡§THE¡¨ Networking Forum for Finding and Keeping Profitable Partners. The networking opportunities will be unparalleled due to the co-location of these premier events and Antibody Production & Downstream Processing celebrating 10 years serving the industry.

Haiduck will address the topic ¡§If Industry Trends are the Antigen, What is Our Partnering Antibody?¡¨ He will cover the latest trends in the biotech industry, the relationship of deal trends to overall biotech industry trends, and how deal trends impact value creation in the antibody company.

Mr. Haiduck¡¦s life sciences experience spans 25 years, including 7 years experience as a biotech deal maker, at both the VP and CEO level, at Geron and Desmos, combined with domestic and international pharmaceutical profit center management for Abbott Laboratories.

Attendees will walk back into their office equipped with:
„h Crucial Techniques for Making Successful Deals
„h Qualified Prospects for New Partnerships and Alliances
„h Multiple Perspectives on Critical Business Decisions
„h Various Strategies for Ensuring that Production Capacity Meets Market Demands
„h Cutting Edge Update on Where the Industry is Heading

ATTENTION CALENDAR EDITORS! For more information on attending Antibody Partnering & Collaboration in La Jolla, March 5-7, 2003, visit http://www.lifesciencesinfo.com/2837 ; call 508-616-5550 or e-mail kpatterson@ibcusa.com.
###